Avalyn Pharma Financials - Benzinga

Avalyn Pharma Inc

AVLNNASDAQ

Trade with Public

Trade with Public

$34.28

-0.70-2%

At close: Sep 15, 5:00 PM EST

$34.28

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Avalyn Pharma Financials

Avalyn Pharma (AVLN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Avalyn Pharma Q2 EPS $(0.65) Misses $(0.53) Estimate

Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22.64 percent.

Benzinga Newsdesk